SCHEMBL12468367

SCHEMBL12468367

CCCCOC(=O)N1CC[C@@H](C=O)C1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.50
LMNA P02545 1/20 0.50
POLB P06746 1/20 0.50
GAA P10253 1/20 0.39
ATM Q13315 2/20 0.39
HPGD P15428 2/20 0.37
GBA2 Q9HCG7 1/20 0.37
ALDH1A1 P00352 3/20 0.37
TSHR P16473 2/20 0.37
CHRM2 P08172 1/20 0.36
CHRM1 P11229 1/20 0.36
HRH2 P25021 1/20 0.36
HRH1 P35367 1/20 0.36
THRB P10828 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
PDE4B Q07343 1/20 0.36
KDM4E B2RXH2 1/20 0.36
MMP3 P08254 2/20 0.35
MMP9 P14780 2/20 0.35
MMP13 P45452 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12468857 1.00 SMN1; SMN2 (0.50) SMN1; SMN2LMNAPOLBGAAATM
SCHEMBL26636947 0.92 POLB (0.48) SMN1; SMN2LMNAPOLBGAAATM
SCHEMBL5500990 0.91 LMNA (0.56) SMN1; SMN2LMNAPOLBGAAATM
SCHEMBL8821262 0.88 LMNA (0.51) SMN1; SMN2LMNAPOLBATMHPGD
SCHEMBL9286227 0.87 SMN1; SMN2 (0.49) SMN1; SMN2LMNAPOLBGAAATM
SCHEMBL9217894 0.86 GAA (0.51) SMN1; SMN2LMNAPOLBGAAATM
SCHEMBL11130437 0.84 LMNA (0.46) SMN1; SMN2LMNAPOLBGAAATM
SCHEMBL3708900 0.80 LMNA (0.54) SMN1; SMN2LMNAPOLBGAAATM
SCHEMBL3652388 0.80 LMNA (0.54) SMN1; SMN2LMNAPOLBGAAATM
SCHEMBL22440438 0.80 SMN1; SMN2 (0.54) SMN1; SMN2LMNAPOLBGAAATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023171736-A1 MEDICINE CONTAINING VITAMIN D DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT OR SOLVATE THEREOF, USED IN COMBINATION WITH IMMUNOMODULATORY SUBSTANCE 帝人ファーマ株式会社 2023-09-14 WO disclosed
WO-2022059684-A1 VITAMIN D DERIVATIVE HAVING CYCLIC AMINE IN SIDE CHAIN 帝人ファーマ株式会社 2022-03-24 WO disclosed
EP-2627630-A1 SEROTONIN REUPTAKE INHIBITORS Theravance, Inc. (US) 2013-08-21 EP disclosed
WO-2012051103-A1 SEROTONIN REUPTAKE INHIBITORS THERAVANCE, INC. (US) 2012-04-19 WO disclosed